
Keywords: DILI, drug-induced liver injury; EBV, Epstein–Barr virus; CMV, cytomegalovirus; HIV, human immunodeficiency virus; HSV, herpes simplex virus; HAV, hepatitis A virus; HBsAg, hepatitis B surface antigen; HBcAb, hepatitis B core antibody; HCV, hepatitis C vi